Amgen recruits European investors for debt sale; BMS, Brazil agree to HIV tech transfer;

 @FiercePharma: Pfizer's Lipitor hardball, from the NYT. The gist: Discounts for PBMs that block generic versions. Article | Follow @FiercePharma

> Amgen ($AMGN) is meeting with European investors this week to prepare to offer up to $1.5 billion in debt denominated in euros and British pounds. Release

> Bristol-Myers Squibb ($BMY) and the Brazilian government have signed a technology transfer agreement to expand access to the AIDS fighter Reyataz. News

> Teva Pharmaceutical Industries' ($TEVA) stock dropped after the Israeli company lost an appeal to stop Watson Pharmaceuticals ($WPI) from selling a generic version of its Seasonique birth control. Item

> GlaxoSmithKline ($GSK) won a tax-overpayment reimbursement of about $4.6 million from one Pennsylvania school district and $6.5 million from another after challenging the assessed values on several properties. More | Report

> Pfizer ($PFE) is continuing to seek buyers for its manufacturing facilities at Rouses Point and Chazy, NY. Story

Biotech News

 @FierceBiotech: BGI, Children's Hospital of Philadelphia team on next-gen sequencing, bioinformatics. Report | Follow @FierceBiotech

 @JohnCFierce: Splitsville for Athersys and Angiotech on stem cell program; Athersys inks $20M stock purchase deal. | Follow @JohnCFierce

 @RyanMFierce: Open R&D biotech model makes sense in researching PTSD. We owe it to veterans with psych scars to team up here. Article | Follow @RyanMFierce

> Analysts debate Xarelto's fate as new data points to $1B ACS market. Story

> Alimera, pSivida shares take a beating on FDA's Iluvien rejection. Report

> WuXi creates $50M VC fund for "great minds" in life sciences. News

Medical Device News

> Report: S&N to raise R&D budget. Item

> OrbusNeich releases data on combo stent, Genous. Report

> Stryker to cut 5% of workforce. Article

Biotech IT News

> Dell puts cloud-computing muscle behind personalized cancer trial. Report

> BGI, Children's Hospital of Philadelphia team on next-gen sequencing, bioinformatics. Article

> Foldit strategies uncovered, spotlights open R&D breakthrough. News

> Y Combinator alum Comprehend lands $1.2M seed round for clinical data analytics. Story

And Finally... Adolescent girls with a family history of breast disease should avoid alcohol, a new study finds. Release

Suggested Articles

After Purdue’s record opioid settlement, more deals could be on the way. But that doesn’t mean all defendants are prepared to go quietly.

Now in their third quarter on the market, Gilead's own Epclusa and Harvoni generics have together grabbed more than 20% of the U.S. hep C market.

Purdue is seeking bankruptcy after inking a $10 billion-plus opioid settlement with thousands of cities and counties, plus two dozen states.